Literature DB >> 2669219

Significance of antibodies to cytoplasmic components of neutrophils.

U Specks1, R A DeRemee.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2669219      PMCID： PMC461830          DOI： 10.1136/thx.44.5.369

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  15 in total

1.  Autoantibodies against cytoplasmic structures of neutrophil granulocytes in Wegener's granulomatosis.

Authors:  G Lüdemann; W L Gross
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

2.  [Anticytoplasmic antibodies as serological markers and activity parameters of Wegener's granulomatosis. A prospective study].

Authors:  G Lüdemann; B Nölle; A Rautmann; S Rosenboom; J Kekow; W L Gross
Journal:  Dtsch Med Wochenschr       Date:  1988-03-18       Impact factor: 0.628

3.  Anti-neutrophil-cytoplasm antibodies in Wegener's granulomatosis are not directed against alkaline phosphatase.

Authors: 
Journal:  Lancet       Date:  1987-06-27       Impact factor: 79.321

4.  Anticytoplasmic antibodies in Wegener's granulomatosis.

Authors:  W L Gross; G Lüdemann; G Kiefer; H Lehmann
Journal:  Lancet       Date:  1986-04-05       Impact factor: 79.321

5.  Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology?

Authors:  D J Davies; J E Moran; J F Niall; G B Ryan
Journal:  Br Med J (Clin Res Ed)       Date:  1982 Aug 28-Sep 4

6.  Microscopic polyarteritis: presentation, pathology and prognosis.

Authors:  C O Savage; C G Winearls; D J Evans; A J Rees; C M Lockwood
Journal:  Q J Med       Date:  1985-08

7.  Association of alkaline phosphatase with an autoantigen recognised by circulating anti-neutrophil antibodies in systemic vasculitis.

Authors:  C M Lockwood; D Bakes; S Jones; K B Whitaker; D W Moss; C O Savage
Journal:  Lancet       Date:  1987-03-28       Impact factor: 79.321

8.  Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis.

Authors:  F J van der Woude; N Rasmussen; S Lobatto; A Wiik; H Permin; L A van Es; M van der Giessen; G K van der Hem; T H The
Journal:  Lancet       Date:  1985-02-23       Impact factor: 79.321

9.  Anticytoplasmic autoantibodies in the diagnosis and follow-up of Wegener's granulomatosis.

Authors:  U Specks; C L Wheatley; T J McDonald; M S Rohrbach; R A DeRemee
Journal:  Mayo Clin Proc       Date:  1989-01       Impact factor: 7.616

10.  Severe glomerulonephritis with late emergence of classic Wegener's granulomatosis. Report of 4 cases and review of the literature.

Authors:  T G Woodworth; J G Abuelo; H A Austin; A Esparza
Journal:  Medicine (Baltimore)       Date:  1987-05       Impact factor: 1.889
View more
  5 in total

1.  Antimyeloperoxidase antibodies in the Churg-Strauss syndrome.

Authors:  J W Tervaert; R Goldschmeding; J D Elema; A E von dem Borne; C G Kallenberg
Journal:  Thorax       Date:  1991-01       Impact factor: 9.139

2.  Anticytoplasmic autoantibody test for Wegener's granulomatosis.

Authors:  L W De Santo
Journal:  West J Med       Date:  1991-06

Review 3.  Respiratory diseases.

Authors:  D G James; O M Sharma
Journal:  Postgrad Med J       Date:  1990-01       Impact factor: 2.401

4.  Ultrastructural localization of proteinase 3, the target antigen of anti-cytoplasmic antibodies circulating in Wegener's granulomatosis.

Authors:  E Csernok; J Lüdemann; W L Gross; D F Bainton
Journal:  Am J Pathol       Date:  1990-11       Impact factor: 4.307

5.  Fibrosing vasculitis in Wegener's granulomatosis: ultrastructural and immunohistochemical analysis of the vascular lesions.

Authors:  D Gindre; S Peyrol; M Raccurt; P Sommer; R Loire; J A Grimaud; J F Cordier
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.